Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2017-01-12

Clinical Trial Update: Long-term Prednisone Use for End-stage Heart Failure [Phase 2, Phase 3]

View source ↗

Summary

A clinical trial update on long-term prednisone use for end-stage heart failure, currently in Phase 2 and Phase 3.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PREDNISONE (Prednisone)

Snippet

Sponsor: Hebei Medical University | Conditions: Heart Failure, Hyperuricemia | Phase 2, Phase 3 | Status: UNKNOWN